Ekman-Lobstein syndrome

There is no satisfactory therapy for many of the disabling genetic disorders such as Ekman-Lobstein syndrome (osteogenesis imperfecta). However, it is hoped that advances arising from the accumulating research evidence can contribute to improving treatment of such conditions. Therefore, reviewing the literature for the recent research evidence is recommended to improve the therapeutic services for such disorders. The occurrence of Ekman-Lobstein syndrome in Iraq has not been documented. In addition to providing the historical documentation of this syndrome, particularly the early history of its documentation, this book describes a case of Ekman-Lobstein syndrome in an Iraqi patient. This book also reviews the available research evidence which may contribute to improving its treatment.

Autorentext

Aamir Jalal Al Mosawi é médico consultor sénior na Cidade Médica de Bagdade. É diretor da sede iraquiana do Painel Internacional de Cientistas Copernicus. É membro da Academia Americana de Pediatria e da Sociedade Britânica de Medicina Genética. Foi membro do conselho consultivo da Associação Internacional de Faculdades de Medicina.